Tesamorelin

Tesamorelin | Targeted Lipodystrophy Research Peptide

A stabilized GHRH analogue studied for its potent impact on visceral adipose tissue and GH secretion.

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group. This modification enhances its stability and potency. In clinical research, it is the primary subject for investigating the reduction of visceral adipose tissue (VAT) and the improvement of metabolic profiles without negatively affecting glucose homeostasis.

Research Benchmarks: Visceral Fat & Growth Hormone

• Adipose Remodeling: Studying the selective reduction of deep abdominal fat.
• Cognitive Research: Investigating the potential neuroprotective effects of GHRH analogues in aging models.
• IGF-1 Modulation: Researching the steady elevation of IGF-1 levels through natural pituitary stimulation.

Scientific Reference Library

• 🧪 Research: Tesamorelin and the reduction of abdominal fat
• 🧪 Research: Pharmacological profile of Tesamorelin
• 🧪 Research: Impact of Tesamorelin on cognitive function in research